| 9/10/2024 | CV | Market Commentary: Hewlett Packard mandatories a ‘blowout’; Ionis drops outright, improves on hedge
|
| 9/10/2024 | CV | Market Commentary: Morning Commentary: Hewlett Packard mandatories eyed; Ionis drops on stock sale
|
| 8/23/2023 | CVLM | Ionis to repurchase $30.2 million of 0.125% convertible notes
|
| 6/12/2023 | CVLM | Ionis reports $434.1 million of 0.125% convertible notes repurchased
|
| 6/12/2023 | CV | Ionis greenshoe exercise ups five-year convertibles to $575 million
|
| 6/8/2023 | CV | Market Commentary: Bread Financial, Ventas Realty offerings oversubscribed; Ionis convertibles up on debut
|
| 6/8/2023 | CV | Market Commentary: Morning Commentary: Bread Financial, Ventas Realty offerings eyed; Ionis gains on debut
|
| 6/8/2023 | CV | New Issue: Ionis prices $500 million five-year convertible notes to yield 1.75%, up 32.5%
|
| 6/7/2023 | CV | Market Commentary: Ionis convertible notes offering oversubscribed, 2026 notes improve; Wayfair in focus
|
| 6/7/2023 | CV | Market Commentary: Morning Commentary: Ionis convertible offering eyed; Wayfair notes in focus early
|
| 6/6/2023 | CVLM | Ionis to repurchase some 0.125% convertibles due 2024
|
| 6/6/2023 | CV | Market Commentary: Coinbase convertibles eyed following SEC lawsuit; Novocure plunges on clinical results
|
| 6/6/2023 | CV | Ionis talks $500 million five-year convertible notes to yield 1.5%-2%, up 27.5%-32.5%
|
| 10/18/2021 | CV | Market Commentary: Opendoor, Cloudflare hit new heights; Revance tanks; Ionis down outright, up on swap
|
| 4/13/2021 | CV | Ionis Pharmaceuticals greenshoe exercised, lifts five-year convertible notes to $632.5 million
|
| 4/9/2021 | CV | Market Commentary: Progress Software contracts on debut; Ionis, Verint below par; Cable One active
|
| 4/8/2021 | CV | Market Commentary: Progress Software eyed; Ionis sees strong start, weakens as session progresses; Li Auto gains
|
| 4/8/2021 | CV | Market Commentary: Morning Commentary: Progress Software eyed; Ionis, Li Auto price
|
| 4/8/2021 | CV | New Issue: Ionis prices upsized $550 million five-year convertible notes to yield 0%, up 32.5%
|
| 4/7/2021 | CV | Market Commentary: Progress Software on tap; Li Auto, Ionis eyed; Verint Systems, Century Aluminum expands
|
| 4/7/2021 | CV | Market Commentary: Morning Commentary: Li Auto, Ionis eyed; Verint Systems, Century Aluminum price
|
| 4/6/2021 | CV | Market Commentary: Ionis, Li Auto on tap; Verint Systems, Century Aluminum eyed; Ceridian active
|
| 4/6/2021 | CV | Ionis Pharmaceuticals talks $500 million five-year convertible notes to yield 0%, up 30% to 35%
|
| 12/13/2019 | CV | Market Commentary: Biotech space firm; Sarepta convertible skyrockets; Ionis notes gain; Lumentum up again
|
| 12/13/2019 | CVLM | Ionis to exchange $35.4 million more 2021 notes for 2024 convertibles
|
| 12/12/2019 | CV | Market Commentary: Impinj convertibles trade flat on debut; Ionis’ new notes skyrocket; Lumentum improves
|
| 12/12/2019 | CV | Market Commentary: Morning Commentary: Impinj convertibles price; Ionis active after exchange; Lumentum up
|
| 12/12/2019 | CVLM | Ionis to issue $398 million convertibles in exchange for 2021 notes
|
| 9/9/2019 | CV | Market Commentary: Convertibles trade in line on swap; profit taking strikes a few names; Insulet drops with shares
|
| 9/9/2019 | CV | Market Commentary: Morning Commentary: Profit-taking strikes convertibles of Neurocrine, Blackstone, Ionis
|
| 4/17/2019 | CV | Market Commentary: Aphria looks cheap; Aqua America trades up in gray market; Ionis expands as stock sinks
|
| 3/21/2019 | CV | Market Commentary: Chegg convertible offering looks cheap, outstanding notes active; GOL Linhas on tap
|
| 8/28/2018 | CV | Market Commentary: Biotech names eyed; Wright Medical convertibles up; Exact Sciences reaches new heights
|
| 4/20/2018 | CV | Market Commentary: New convertible paper quiet; Clovis contracts; Ionis, NXP in focus in secondary market
|
| 10/24/2017 | CV | Market Commentary: Ionis down in active trade; Nabors off; Illumina in line as investors eye earnings
|
| 10/24/2017 | CV | Market Commentary: Morning Commentary: Ionis down in active trade as shares drop; Nabors Industries weakens
|
| 10/16/2017 | CV | Market Commentary: Convertible bond players shuffle paper as stock rise continues; primary remains quiet
|
| 1/6/2017 | CV | Market Commentary: Biotech sector firm, led by Medicines, Ionis; Pandora convertibles in decline; Colony dips
|
| 1/6/2017 | CV | Market Commentary: Morning Commentary: Biotech sector firm, led by Medicines, Ionis; Pandora convertibles in decline
|
| 8/2/2016 | CV | Market Commentary: DISH to bring $2 billion of convertibles; NextEra also on tap; Cobalt paper declines
|
| 5/31/2016 | CV | Market Commentary: Health care in focus as sector lifts; Softbank mandatory exchangeable into Alibaba on tap
|
| 5/26/2016 | CV | Market Commentary: New WebMD gains on debut; existing WebMDs mixed; Renewable Energy to price; Ionis plunges
|
| 3/15/2016 | CV | Market Commentary: Valeant woes cast a pall over convertible biotech/health care; energy shows resilience
|
